Eleonora Tamborini Permunian
Overview
Explore the profile of Eleonora Tamborini Permunian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grandone E, Tiscia G, Mastroianno M, Larciprete G, Kovac M, Tamborini Permunian E, et al.
Hum Reprod
. 2021 Jul;
36(8):2083-2090.
PMID: 34195794
Study Question: What evaluation and care is offered to women after unexplained recurrent pregnancy loss (RPL) or intra-uterine foetal death (IUFD) and what are the reproductive outcomes? Summary Answer: Women...
2.
Brucato A, Ferrari A, Tiraboschi M, Zucchi A, Cogliati C, Torzillo D, et al.
Eur J Intern Med
. 2019 Nov;
72:60-66.
PMID: 31757579
Objective: To predict the 3-months mortality in permanently bedridden medical non-oncologic inpatients. Patients And Methods: 2788 consecutive patients admitted in 5 Italian Internal Medicine units from January 2016 through January...
3.
Villani M, Baldini D, Totaro P, Larciprete G, Kovac M, Carone D, et al.
BMC Pregnancy Childbirth
. 2019 Aug;
19(1):292.
PMID: 31409287
Background: Spontaneous pregnancy loss and implantation failure after assisted reproductive technologies (ART) are very common occurrences. Although 50-60% of all cases remains unexplained, various predisposing factors, including thrombophilias, have been...
4.
Tamborini Permunian E, Gervaso L, Gerdes V, Moja L, Guasti L, Squizzato A
Intern Emerg Med
. 2018 Apr;
13(5):775-790.
PMID: 29611106
Direct-acting antiviral drugs (DAAs) were recently approved for treating hepatitis C virus-related chronic hepatitis. As advanced chronic liver disease may predispose patients to thrombotic events, it is still uncertain whether...
5.
Tamborini Permunian E, Mumoli N, Callegari L, Tragni C, Ageno W
Intern Emerg Med
. 2017 Jun;
12(6):817-819.
PMID: 28577149
No abstract available.
6.
Mumoli N, Tamborini Permunian E, Vitale J, Cei M, Giorgi-Pierfranceschi M, Brondi B, et al.
J Am Geriatr Soc
. 2016 Jan;
64(1):213-5.
PMID: 26782881
No abstract available.
7.
Riva N, Dentali F, Tamborini Permunian E, Ageno W
Semin Thromb Hemost
. 2016 Jan;
42(1):42-54.
PMID: 26751034
The novel direct oral anticoagulants (DOACs) have been proposed as alternatives to low-molecular-weight heparins (LMWHs) for the prevention of venous thromboembolism in orthopedic surgery. However, the clinical impact of postsurgical...
8.
Tamborini Permunian E, Riva N, Guasti L, Squizzato A
Expert Opin Drug Metab Toxicol
. 2015 Mar;
11(4):625-37.
PMID: 25728292
Introduction: Dual antiplatelet therapy is the standard of care for patients with acute coronary syndromes or with recent coronary stents implantation. P2Y12 receptor antagonists have shown to reduce the risk...
9.
Lussana F, Squizzato A, Tamborini Permunian E, Cattaneo M
Thromb Res
. 2014 Jul;
134(3):599-603.
PMID: 25064034
Introduction: Major surgery is associated with increased risk of venous thromboembolism (VTE), which is decreased by anticoagulant drugs. Evidence is growing that major surgery is associated with increased risk of...